CARCINOMA

This adverse event was reported 270 times

These drugs are most commonly taken by patients reporting CARCINOMA:

# Drug Count
0 OXYCODONE HYDROCHLORIDE 54
1 THALIDOMIDE 21
2 INFLIXIMAB 15
3 CLOZAPINE 14
4 INTERFERON BETA-1A 14
5 INSULIN HUMAN 10
6 MORPHINE SULFATE 9
7 ESOMEPRAZOLE MAGNESIUM 7
8 INSULIN LISPRO 7
9 METHOTREXATE SODIUM 7
See all common drugs associated with CARCINOMA

CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE 1 0.0031
1 BROMPHENIRAMINE MALEATE 1 0.0028
2 DIPHENHYDRAMINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE 1 0.0028
3 AMIFOSTINE 1 0.0012
4 INTERFERON GAMMA-1B 1 0.0007
5 PHENELZINE SULFATE 1 0.0006
6 IMIGLUCERASE 3 0.0006
7 THALIDOMIDE 21 0.0006
8 ACETAMINOPHEN AND CODEINE PHOSPHATE 1 0.0005
9 SULINDAC 1 0.0004
See all drugs enriched for association with CARCINOMA

CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interferon gamma [EPC] 1 0.0007
1 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 3 0.0004
2 Insulin [EPC] 10 0.0002
3 Sulfone [EPC] 1 0.0001
4 Interferon beta [EPC] 14 0.0001
5 Nitrofuran Antibacterial [EPC] 1 0.0001
6 Atypical Antipsychotic [EPC] 17 0.0000
7 Estrogen [EPC] 5 0.0000
8 Estrogen Receptor Antagonist [EPC] 1 0.0000
9 Insulin Analog [EPC] 10 0.0000
See all drug classes enriched for association with CARCINOMA